Trial NCT01517984

View at ClinicalTrials.gov 
Org. Study IDs: DAIT CTOT-09

Last trial update was posted on 2017-09-11

MeSH Interventions

Antilymphocyte Serum Calcineurin Inhibitors Immunosuppressive Agents Mycophenolic Acid Prednisone Tacrolimus Thymoglobulin

MeSH Conditions


Other Conditions

Kidney Transplant Recipients

Stopping Reasons

Absence of equipoise on the basis of predetermined stopping rules.

Limitations And Caveats

After meeting protocol stopping rules, this trial was closed to new enrollment and randomization. No additional prespecified withdrawal of tacrolimus was allowed. Those already enrolled or randomized were followed for up to 24 months post-transplant.

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID